Risk Prediction Models for Lung Cancer: A Systematic Review
Affiliations.
- 1 Department of School of Health and Related Research, University of Sheffield, Sheffield, United Kingdom. Electronic address: [email protected].
- 2 Department of School of Health and Related Research, University of Sheffield, Sheffield, United Kingdom.
- PMID: 26712102
- DOI: 10.1016/j.cllc.2015.11.007
Many lung cancer risk prediction models have been published but there has been no systematic review or comprehensive assessment of these models to assess how they could be used in screening. We performed a systematic review of lung cancer prediction models and identified 31 articles that related to 25 distinct models, of which 11 considered epidemiological factors only and did not require a clinical input. Another 11 articles focused on models that required a clinical assessment such as a blood test or scan, and 8 articles considered the 2-stage clonal expansion model. More of the epidemiological models had been externally validated than the more recent clinical assessment models. There was varying discrimination, the ability of a model to distinguish between cases and controls, with an area under the curve between 0.57 and 0.879 and calibration, the model's ability to assign an accurate probability to an individual. In our review we found that further validation studies need to be considered; especially for the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial 2012 Model Version (PLCOM2012) and Hoggart models, which recorded the best overall performance. Future studies will need to focus on prediction rules, such as optimal risk thresholds, for models for selective screening trials. Only 3 validation studies considered prediction rules when validating the models and overall the models were validated using varied tests in distinct populations, which made direct comparisons difficult. To improve this, multiple models need to be tested on the same data set with considerations for sensitivity, specificity, model accuracy, and positive predictive values at the optimal risk thresholds.
Keywords: Clinical utility; Prediction models; Prediction models' design; Prediction models' discrimination; Validation results.
Copyright © 2016 Elsevier Inc. All rights reserved.
Publication types
- Research Support, Non-U.S. Gov't
- Systematic Review
- Decision Support Techniques*
- Early Detection of Cancer / methods
- Lung Neoplasms / diagnosis*
- Lung Neoplasms / epidemiology
- Models, Statistical
- Predictive Value of Tests
- Risk Assessment
- Risk Factors
- Sensitivity and Specificity
IMAGES
VIDEO
COMMENTS
Lung cancer remains a devastating diagnosis to receive. The goal of this thesis was to better understand the impact of lung cancer and study how to integrate palliative and supportive care. We ...
Therefore lung cancer has the highest mortality rate in the U.S., with a 5-year relative survival rate for stage IV lung cancer being 4% [2]. If the 5-year relative survival rates for different stages are merged, the survival rate for small cell lung cancer is only 6%, whereas the rate for non-small cell lung cancer is 23% [2].
The 100 most cited articles in lung cancer are listed in Table 1, arranged in descending order according to the number of times cited. The number of citations ranged from 7751 to 889, and the mean number of citations per article was 1879.82 ±1264.78 (range: 7751-889). We found that the most cited article (times cited: 7751) on lung cancer ...
MeSH terms. Lung cancer is one of the most frequently diagnosed cancers and the leading cause of cancer-related deaths worldwide with an estimated 2 million new cases and 1·76 million deaths per year. Substantial improvements in our understanding of disease biology, application of predictive biomarkers, and ref ….
Design. This is an exploratory study that used a phenomenological-hermeneutic approach (Dreyer & Pedersen, 2009) to deeply understand the connotation of MoL in patients with advanced lung cancer, and to reveal the complexity of MoL and its impact on self.A phenomenological perspective attaches importance to rich contextualized descriptions based on experience, and helps the researcher to look ...
both limited-stage small cell lung cancer patients and extensive-stage small cell lung cancer patients throughout the study period. Lu et al. (2019) demonstrated that the average incidence of lung cancer was 59.0/100,000 people for the years from 1973 to 2015. Specifically, the incidence rate was at an apex in 1992 and then constantly declined.
Abstract. Lung cancer is the leading cause of cancer deaths worldwide among both men and women, with more than 1 million deaths annually. Non-small cell lung cancer (NSCLC) accounts for about 80% of all lung cancers. Although recent advances have been made in diagnosis and treatment strategies, the prognosis of NSCLC patients is poor and it ...
Lung Cancer Screening Program Revenue April 2016 verses 2017. A 2012 study found lung cancer screening to be one of the most cost-effective. screening tests available at about $11,000 per life-year saved, compared with $18,000 for. colon cancer screening, $31,000 for breast cancer screening, and $50,000 for cervical.
Creator. Peterson, Bobbie Jo. Affiliation: School of Nursing; Abstract. Low-dose chest tomography (LDCT) screening in high-risk patients (individuals age 55-74 with a 30-pack-year smoking history in a current smoker, or similar smoking history in a former smoker who quit within the past 15 years) has proven to reduce both lung cancer and all-cause mortality by 20% and 7%, respectively (Aberle ...
Lung cancer (LC) is among the most common and deadliest malignancies worldwide. According to Global Cancer Incidence, Mortality, and Prevalence, LC ranks second globally in terms of incidence, with over 2.2 million new cases estimated to have occurred in 2020, and first in terms of mortality, with nearly 1.8 million caused deaths. 1 Despite the continuous improvement of treatment modalities (i ...
Lung cancer is a disease of uncontrolled cell growth in tissues of the lung. This growth may lead to metastasis, which is the invasion of adjacent tissue and infiltration beyond the lungs. The ...
Abstract. Many lung cancer risk prediction models have been published but there has been no systematic review or comprehensive assessment of these models to assess how they could be used in screening. We performed a systematic review of lung cancer prediction models and identified 31 articles that related to 25 distinct models, of which 11 ...
This thesis will be defended in public on Wednesday 24 February 2016 at 11:00 hrs by Ali Saber Hosseinabadi born on 11 September 1981 in Rasht, Iran . ... Lung cancer is classified into non-small cell lung cancer (NSCLC), which accounts for approximately 85% 3of all cases, and small cell lung cancer (SCLC) . There are
The synopsis of the literature provides a thorough examination of several DL and digital image processing methods used in the identification of cancer, with a primary emphasis on lung and colon cancer. The experiments use the LC25000 dataset, which consists of 25,000 photos, for the purposes of training and testing.
The primary focus of this thesis is on cancer cells of different invasive potential, and char-acterization of inherent properties that differ between non-invasive and invasive strains of similar origin. To understand our motivation we will outline some of the main aspects of cancer cells, especially in respect to their survival and spreading.
Introduction. According to cancer statistics released in the United States, lung cancer has become the second most prevalent cancer, but it still occupies the top spot for cancer deaths over 50 years of age (Siegel et al., 2023).The World Health Organisation's International Agency for Research on Cancer (IARC) recently released the latest global cancer burden data for 2020, and China ranked ...
Lung cancer. Alesha A Thai, Benjamin J Solomon, Lecia V Sequist, Justin F Gainor, Rebecca S Heist. Lung cancer is one of the most frequently diagnosed cancers and the leading cause of cancer-related deaths worldwide with an estimated 2 million new cases and 1·76 million deaths per year. Substantial improvements in our understanding of disease ...
Screening for lung cancer in high-risk individuals can also help detect the disease at an early stage. How can a thesis statement help with lung cancer prevention? A thesis statement is a clear and concise sentence that outlines the main argument or purpose of a research paper. When writing a paper on lung cancer prevention, a well-crafted ...
INTRODUCTION. Every year approximately 160,000 persons, primarily elders, die from lung cancer; the leading cause of cancer mortality in the United States (American Cancer Society, 2009).Given the rapid deteriorating course of illness, prevalence of uncontrolled symptoms (Griffin, Koch, Nelson, & Cooley, 2007), and stigma associated with lung cancer that is reported by smokers and non-smokers ...